Check the B6 (pyridoxine) dose on any B-complex you're taking. If it says "B-100" or lists B6 at 100mg, stop taking it — that's 8 times the European safe limit and the dose range linked to peripheral neuropathy. Switch to a low-dose B-complex (B6 under 12mg) or individual vitamins only if you have a confirmed need.
Think of B vitamins as the specialized tools in a workshop. Your body's metabolic "workshop" already has a full set of tools from food. Adding more tools doesn't make the workshop run faster — it just crowds the bench. But if someone stole your B12 (as metformin and PPIs do), or your body can't sharpen folic acid into its usable form (the MTHFR gene variant), then the workshop genuinely stalls.
That's the general answer. Your stack is different.
Check your whole stackThe energy supplement that doesn't boost energy — and the safe dose is lower than you think
CONDITIONALDo This First
Check the B6 (pyridoxine) dose on any B-complex you're taking. If the label says "B-100" or lists B6 at 100mg, stop taking it — that's 8 times the European safe limit, in the dose range linked to peripheral nerve damage. Switch to a low-dose B-complex (B6 under 12mg) or, if you don't have a confirmed need, skip it entirely.
B-complex supplements are genuinely essential for some people — but useless for most healthy adults, and potentially harmful in the wrong product.
Vegans (B12 is only in animal foods), elderly with memory concerns + high homocysteine, anyone on metformin or long-term acid blockers, MTHFR gene variant carriers, and people trying to conceive (folate).
You're a healthy omnivore under 50 with no medications or confirmed deficiency — a varied diet covers your B vitamin needs. Don't spend money on symptoms you don't have.
Want the full evidence? Keep scrolling ⌄
| Population | What's Needed | Daily Dose | Form | Source |
|---|---|---|---|---|
| Healthy omnivore, under 50 | Nothing — food sufficient | N/A | Food-first | NIH ODS |
| Vegans / strict vegetarians | B12 — essential (zero plant sources) | 500–1,000µg B12 | Cyanocobalamin or methylcobalamin | NIH ODS |
| Elderly >65 with MCI + elevated homocysteine (>13 µmol/L) | VITACOG protocol | 0.8mg folate, 0.5mg B12, 20mg B6 | 5-MTHF preferred, methylcobalamin or cyanocobalamin | Smith 2010 (VITACOG) |
| Metformin users (>4 years) | B12 — metformin blocks ileal absorption | 500–1,000µg B12 | Cyanocobalamin or hydroxocobalamin | PMID 15289206 |
| Long-term PPI users | B12 — PPIs block acid needed for food-bound B12 absorption | 500–1,000µg B12 | Cyanocobalamin (high-dose oral bypasses passive absorption) | NIH ODS |
| MTHFR C677T homozygotes | Active folate form — bypasses enzyme defect | 400–800µg 5-MTHF | Methylfolate (5-MTHF) only — not folic acid | Lamers 2004 |
| Preconception / pregnant | Folate — neural tube defect prevention | 400µg/day (start 3+ months before conception) | 5-MTHF preferred; folic acid accepted | EFSA Scientific Opinion |
| Form | Stability | Best Evidence For | Cost | Notes |
|---|---|---|---|---|
| Cyanocobalamin | High (shelf-stable) | General maintenance, vegans — one trial showed superior active B12 (holotranscobalamin) levels vs methylcobalamin in vegans | Low | Requires trace cyanide cleavage before activation — excreted safely; highly stable during manufacturing |
| Methylcobalamin | Lower (heat/light sensitive) | Neuropathy, active methylation support, bypasses conversion step | High | Active form immediately; more prone to manufacturing degradation — label potency may not match actual dose |
| Hydroxocobalamin | High | IM injection for severe deficiency; preferred depot form | Medium | Longest tissue retention of all forms; prescription for injection |
| Form | MTHFR Dependence | UMFA Risk | Best For |
|---|---|---|---|
| Folic acid (synthetic) | Required — bottlenecked in TT homozygotes | Yes — unmetabolized folic acid accumulates in replete adults (theoretical cancer concern) | General population, fortification — works well if MTHFR normal |
| 5-MTHF (methylfolate) | None — bypasses MTHFR entirely | Zero — no UMFA produced | Everyone — universally bioavailable regardless of genotype; superior for MTHFR TT carriers (8-11% of population with ~70% enzyme reduction) |
| Folinic acid (leucovorin) | Partial | Zero | Methotrexate rescue in oncology (prescription) |
EFSA 2023 revised the safe upper intake level for B6 (pyridoxine) to 12mg/day — down from 100mg. Clinical data shows paresthesia (tingling/numbness) in 48% of women taking less than 50mg/day for over 6 months. Most "B-100 Complex" products contain 100mg. Australian TGA now mandates neuropathy warnings on any product above 10mg/day. Count B6 from all sources: multivitamin + B-complex + fortified foods can easily exceed this threshold.
| Medication | Interaction | Severity | Management |
|---|---|---|---|
| Phenytoin / Anticonvulsants | Folic acid accelerates phenytoin metabolism, dropping blood levels 20-40% — can trigger breakthrough seizures in stable epilepsy patients | SEVERE | Do NOT add folic acid supplements without neurologist review and therapeutic drug monitoring |
| Methotrexate (RA/inflammatory — low dose) | MTX inhibits folate reductase; without folate supplementation, causes hepatotoxicity and GI mucositis — but folic acid does NOT reduce MTX efficacy in RA | SEVERE | Standard of care: ≥5mg folic acid/week taken on non-MTX days — but consult prescribing physician for timing |
| Metformin (long-term) | Blocks calcium-dependent B12 absorption in the terminal ileum; up to 30% of long-term users develop clinically significant B12 deficiency — neuropathy may mimic diabetic neuropathy | MODERATE-HIGH | Monitor serum B12 / holotranscobalamin annually after 4 years; supplement 500-1,000µg/day orally if below range |
| Proton Pump Inhibitors (omeprazole, etc.) | Raises gastric pH, preventing release of food-bound B12 from proteins; risk compounds when combined with metformin (OR 2.60 for B12 deficiency) | MODERATE | Monitor B12 in long-term PPI users, especially if also on metformin |
| High-dose Niacin (B3) >1,000mg/day | Induces insulin resistance, elevates uric acid (gout risk), prostaglandin-mediated flushing; distinct from low-dose dietary niacin | MODERATE | Monitor HbA1c, uric acid, liver enzymes; use extended-release form; pharmacological niacin for dyslipidemia requires medical supervision |
| Levodopa (modern formulation with carbidopa) | Historically significant: B6 accelerated peripheral dopamine conversion. Rendered obsolete by carbidopa/benserazide co-formulations; B-complex is now recommended with L-dopa to prevent drug-induced hyperhomocysteinemia | LOW (HISTORICAL) | No action needed with modern formulations; confirm patient is on carbidopa/levodopa combination, not plain levodopa |
| B Vitamin | Safe Upper Limit | Authority | Toxicity Signs |
|---|---|---|---|
| B6 (Pyridoxine) | 12mg/day | EFSA 2023 (↓ from 25mg) | Sensory neuropathy, tingling hands/feet, ataxia — can be slow to reverse |
| B3 (Niacin) | 35mg/day (flush threshold); pharmacological >1,000mg needs supervision | NIH UL | Flushing, insulin resistance, hyperuricemia, hepatotoxicity at high doses |
| B9 (Folic acid — synthetic) | 1,000µg/day | NIH UL | Masks B12 deficiency hematological signs while neuropathy advances |
| B12, B1, B2, B7 | No established UL | NIH ODS | B12: rare acneiform eruptions; others essentially non-toxic at typical supplemental doses |
The Verdict — Weekly
Want to stop paying for supplements that don't do what the label claims? The Verdict breaks down one supplement per week with full evidence — free.
Join The Verdict — FreeHow strong is the evidence for the claims in this review? Higher = more confidence the claims are supported. This does not measure how large the effect is or how important it is compared with other levers.
Is this worth your time, money, effort, risk, and trust for this goal? Different from Verdict Score (evidence strength) and Leverage Map (relative importance) — Action ROI is the worth-it call once friction is priced in.
Evidence-scored dosing, timing, forms, and who should skip it. One page, no fluff.
Get the protocolConviction-scored verdicts on supplements, nutrition, training, physio, and recovery.